Savvy Update, 4/11/22: Legislation Targets Abusive Pharma Practices, 1st US Implant of Eversense E3 CGM, Voice May Predict Heart Disease, Ultrasound to Treat T2D, Bioprinted Pancreas

Savvy Update, 4/11/22: Legislation Targets Abusive Pharma Practices, 1st US Implant of Eversense E3 CGM, Voice May Predict Heart Disease, Ultrasound to Treat T2D, Bioprinted Pancreas

Maloney, Stabenow, and Smith Lead Colleagues in Introducing Legislation to Target Abusive Pharmaceutical Business Practices was published by the House Committee on Oversight and Reform, 7 April 2022.   Rep. Carolyn B. Maloney, Chairwoman of the House...
Savvy Update, 2/28/22: Beta Bionics Gets More Funding, Scanbo Sensor, World Diabetes Data, Light & Insulin Resistance, Digital Apps Get CMS Codes, PMBs Responsible for Drug Prices, TikTok on CRISPR

Savvy Update, 2/28/22: Beta Bionics Gets More Funding, Scanbo Sensor, World Diabetes Data, Light & Insulin Resistance, Digital Apps Get CMS Codes, PMBs Responsible for Drug Prices, TikTok on CRISPR

Beta Bionics Announces Closing of $57 Million Series C Financing as reported on GlobeNewswire.com, 17 February 2022.   Beta Bionics, Inc. — a clinical stage medical technology company committed to the design, development, and commercialization of the iLet®...
Skip to content